SEC Form 4 · accession 0001209191-18-058417
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis T Williams
Officer — Executive Chairman · Director
Period of report
Nov 5, 2018
Accepted (ET)
Nov 13, 2018 · 8:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 5, 2018 | M | 91,217 | $4.56 | A | 465,430 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $4.56 | Nov 5, 2018 | M | 91,217 | D | — | Apr 15, 2019 | Common Stock | 91,217 | 0 | D |
Explanation of responses
- F1This option is fully vested and immediately exercisable.